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Abstract   We designed and evaluated a microfluidic test chip for human blood filtration and imaging label-free 
detection of multiple biomarkers. The microfluidic chip has a total size of 75 mm x 25 mm x 2 mm. It is realized 
as an assembly of a plastic chip and a functionalized photonic crystal slab on a glass substrate. The plastic chip 
contains capillary channels, a filter membrane and a cavity open on one side. The photonic crystal chip is bonded 
with an adhesive foil to the open cavity. Human blood filtration is demonstrated. We determined that 
fluorescently labelled particles of diameter 3µm or larger are filtered out by the system. Refractometric 
measurements are performed with the test chip in combination with a compact imaging read-out system to 
investigate the system response to refractive index changes. Flow dynamics in the sensor cavity are imaged for 
replacing water by isopropanol. Finally, the binding of 500 nM biotin dissolved in phosphate buffer saline to a 
photonic crystal surface locally functionalized with streptavidin is demonstrated. 
 
1 Introduction 
Compact, fast-operating, decentralized and easy-to-use sensors are of high interest for point-of-care applications. 
These requirements can be met by combining microfluidic technology with an integrated biosensor [1, 2]. 
Microfluidic systems enable biochemical analyses using small reagent volumes [3]. Compared to conventional 
diagnostic devices in centralized facilities the small reagent volume needed in microfluidic systems is beneficial 
especially for human blood filtration and thus for biomarker analyses in blood [4]. Different concepts were 
introduced to separate plasma from whole blood such as special filter materials [5], designed filtration channels 
[4, 6], or separation via a membrane [7]. If a photonic crystal biosensor is integrated in such a microfluidic 
system, a label-free, compact and cost efficient system may be realized [2, 8, 9]. Photonic crystal slabs (PCS) are 
waveguides with a periodic nanostructure in a high refractive material supporting quasi-guided modes. These 
modes are visible as guided-mode resonances (GMRs) in the optical transmission and reflection spectrum. 
Because of the evanescent fraction of the quasi-guided modes propagating above the PCS surface, refractive 
index changes on the PCS surface result in a wavelength shift of the GMRs. When functionalizing the PCS 
surface with ligands, binding kinetics of the specific target proteins result in a refractive index change above the 
PCS surface and thus to a red-shift of the resonance wavelength. This can be tracked in real time with an optical 
read-out system [8-10]. Previously, optical read-out of the resonance spectral position was evaluated with a 
sensitive spectrometer for other microfluidic devices [9]. We developed an imaging read-out system, which 
converts the resulting shift of resonances in the transmission spectrum into an intensity change in the specific 
colour channel of a simple CMOS camera aligned to the resonance wavelength [11]. With such a system we are 
able to detect multiple biomarkers in parallel. In previous works we demonstrated the functionality of a label-
free photonic crystal biosensor and our imaging read-out system by successfully performing detections of 90 nM 
CD40 ligand antibody as well as of 250 nM streptavidin. Additionally, we suggested the concept of a 
microfluidic test chip for blood filtration and presented first binding experiments [12]. This system concept is 
depicted in figure 1. Here, we investigate in detail the properties of the microfluidic test chip. First we evaluate 
the filter properties of our microfluidic test chip conducting experiments with whole blood as well as with 
fluorescently labelled particles of different diameters. Second, the flow characteristics in the cavity of the test 
chip are investigated by performing refractometric measurements with our imaging read-out system. Finally, 
spatially-resolved binding experiments are performed with the biotin-streptavidin system. 
 
Figure 1: Schematic of microfluidic system for detection of multiple biomarkers with filter unit and bonded sensor chip. Label -
free read-out is performed with a compact imaging system and a camera.  
2 Results and Discussion 
2.1 Test chip design and evaluation 
We designed a microfluidic test chip with a total size of 75 mm x 25 mm x 2 mm. It is realized as an assembly of 
a plastic microfluidic chip and a functionalized photonic crystal slab on a glass substrate. The plastic 
microfluidic chip was developed in cooperation with the company Microfluidic ChipShop GmbH. As it is shown 
in figure 2a, the plastic microfluidic chip consists of a main chip and a cover plate. The main chip includes a 
filler neck for the application of whole blood, capillary channels for blood guidance and a 15 x 15 mm² cavity. 
The cover plate includes a filter membrane for blood filtration and an adhesive foil for bonding on the photonic 
crystal sensor chip with an adhesive foil.  
 
Figure 2: (a) Computer aided-design of a plastic microfluidic main chip including filler neck for whole blood, capillary channels 
and cavity for sensor (top) plus cover plate including blood filter membrane and adhesive foil for sensor bonding (bottom) ; (b) 
layout of the microfluidic test chip and human blood injection with a pipette through the filter; (c) microscope image of blood 
serum in the sensor cavity. 
Blood filtration experiments were performed by injecting 200 µl of whole blood spiked with the anticoagulant 
heparin to inhibit an immediate coagulation inside the capillary channels, which could appear due to surface 
enlargement. The red blood cells remain in the membrane and the clear blood serum (approx. 70-100 µl) is 
transported to the sensor cavity, as seen in figures 2b. The microscopy image in figure 2c reveals that 
nevertheless a plenitude of blood components pass the filter and reach the cavity. This explains the schlieren 
observed previously in imaging detection with the photonic crystal sensor [12]. As larger particles deteriorate the 
label-free detection scheme, we next consider in detail, which particle sizes pass the filter. 
 
For this purpose particles in different sizes (200 nm, 1 µm, 2 µm, 3 µm and 5 µm) labelled with the fluorescence 
dyes DAPI (4',6-Diamidino-2-phenylindole), or FITC (Fluorescein isothiocyanate) were used. They were 
dissolved in doubled-distilled water. A glass substrate was bonded to the microfluidic plastic chip instead of the 
PCS sensor. Then, 200 µl of the solution were injected with a pipette and pressed into the capillary channels and 
through the filter membrane. An image of the filtered solution reaching the sensor cavity was captured separately 
for each particle size with a fluorescence microscope. Exemplary, two recorded fluorescence images are shown 
for the particle sizes of 1 µm (figure 3a) and of 3 µm (figure 3b). Figure 3b shows that 3 µm particles remain 
inside the filter membrane. However, the 200 nm and 1 µm particles pass the filter and reach the sensor field. 
Additionally, some of the particles were labelled with acid or amino groups to check for chemical interactions 
with the filter membrane. No influence could be observed. In the next microfluidic chip generation it is desirable 
to filter out smaller particles to prevent schlieren that deteriorate the imaging measurement. Furthermore, a 
redesign of the sensor cavity is necessary. 
 
 
Figure 3: (a) Fluorescence photograph of 1μm large particles recorded in the sensor cavity; (b) fluorescence micrograph of 3μm 
large particles recorded in the filter membrane. 
 
2.2. Refractometric measurements and protein detection 
The aim is to perform a multiparameter test by local functionalization of the photonic crystal sensor chip and 
imaging readout. This test requires high homogeneity of the sensor signal across the sensor chip. Here, we 
investigate the signal homogeneity by performing imaging refractometric measurements. For this purpose a non-
functionalized PCS was bonded into the microfluidic plastic chip and an analyte change from distilled water to 
isopropanol is conducted. As the quasi-guided mode samples the analyte refractive index, a change in the GMRs 
occurs. The test chip is placed in the imaging read-out system between two crossed linear polarizing filters and a 
parallelizing and focussing optic [12]. Because of this set-up only light interacting with the quasi-guided modes 
is transmitted through the crossed polarizers to the CMOS sensor of a simple camera [13]. An orange light 
emitting diode (LED) is used as excitation source and the resonance wavelength is aligned to the falling edge of 
the LED spectrum. Thus, a wavelength shift of the resonance is converted into an intensity reduction. The 
spatially-resolved transmission intensity is recorded by the CMOS camera sensor. During the measurement we 
acquired camera images of the sensor surface every 0.5 seconds. Here, only the green colour channel of the 
camera was read out with a LabVIEW program. Corresponding to the LED and the GMR spectrum the 
sensitivity of the green colour channel also has a falling edge in this spectral range. This enhances the intensity 
response to changes of the surrounding refractive index additionally. Figure 4a shows an example of a recorded 
image.  
 
To generate a baseline signal the test chip was filled with water (nH2O=1.33). After seven minutes the water was 
replaced by isopropanol (niso=1.37). For figure 4b the mean values of the two measuring fields (M1 & M2) are 
calculated for each taken photograph and the resulting intensity values are plotted against time. For both signal 
sequences an intensity reduction of ΔI= 17.12 % is observed after 15 minutes. We calculated a limit of detection 
(LOD) of around 7.3×10
-4
 RIU. The LOD is defined as LOD = ((3 × σ) / ΔI) × Δn with σ as the standard 
deviation of the baseline signal, ΔI as the intensity difference and Δn as the refractive index difference of the 
analytes.  
  
Figure 4: (a) Recorded photograph of the sensor field with the imaging read-out system. The sensor field and measuring fields 
M1 and M2 are marked with black dashed rectangles. The adhesive foil as well as the inlet  channel can be seen on this picture; 
(b) the mean value within the measuring fields is calculated for each photograph and the intensity values are plotted against time . 
To investigate the homogeneity of the signal, the first recorded photograph is subtracted from every following 
photograph and the difference intensity images are analysed as a movie. Figure 5 depicts six examples of 
difference images with the above used measuring fields marked again as black dashed rectangles. In the movie it 
is observed that already before the isopropanol injection intensity differences are recorded around the measuring 
field M2. These are seen in the difference image at 2.02 minutes shown in figure 5. We attribute these changes to 
mechanical stress deformations of the microfluidic test chip. The isopropanol is guided via the inlet into the 
sensor field and reaches the field at 6.8 minutes. Figure 5 shows that already at 7.04 minutes (14 seconds after 
isopropanol injection) a refractive index change is observed across the entire sensor cavity. For the next 40 
seconds rapid fluctuations of the difference intensity image are observed that may be attributed to flow 
dynamics. After approximately 1 minute a steady state is achieved in the top-right half of the test chip. The 
images at 7.70 minutes and 15.0 minutes are similar in this region. On the bottom left on the other hand, further 
intensity changes are observed. Visually, these could be attributed to the formation of an air bubble. This leads to 
the assumption that the bonding adhesive is not stable against isopropanol. Instead of isopropanol glycerol may 
be used for system verification in the future. Furthermore, additional bubble formation is observed at the inlet. 
Figure 6 presents difference images at different times showing the rapid change in intensity upon injection and 
the much smaller changes before and after injection. The intensity reduction at the upper edge of the sensor field 
observed in figure 6c occurs from air accumulation caused by the rise of air bubbles. 
 
Considering the difference image in figure 5 at 15 minutes, highly inhomogeneous intensity changes are 
observed within the sensor field. As isopropanol has a homogeneous refractive index, we expected to observe an 
intensity reduction distributed homogeneously over the whole sensor field and thus a shift of the distribution 
towards lower grey scale values. We attribute this inhomogeneity to mechanical deformation upon injection of 
isopropanol. This behaviour is highly detrimental for an imaging biosensor and should be prevented by a more 
stable microfluidic test chip layout in the next design generation. Therefore, a more stable mechanical design of 
the chip is targeted in the next generation. This may be achieved by thicker substrates. Additionally, the large 
square cavity may be replaced by a meandering channel that is better supported by sidewalls. For such an 
approach the dwell time of the biomarkers on top of the sensor fields need to be optimized. 
 
Figure 5: Examples of intensity difference images with the first photograph subtracted for each investigated time. Isopropanol 
injection occurs at 7 min close to measuring field M2. 
 Figure 6: Intensity difference images between different points in time. (a) Image at 4.80 min minus the one at 2.23 min. (b) Image at 7.20 
min minus the one at 6.74 min. (c) Image at 13.32 min minus the one at 10.55 min 
 
Nevertheless, we performed first binding experiments by immobilizing initially two drops of 1.00 µM of 
biotinylated bovine serum albumin (BSA-biotin) and then 1.00 µM of streptavidin via covalent coupling on the 
surface of the photonic crystal [12]. Afterwards, 500 nM BSA-biotin dissolved in phosphate buffer saline were 
injected into the test chip to simulate measurement conditions as they exist for binding experiments with whole 
blood. The test chip was placed inside the imaging read-out system and images were taken continuously during 
the protein detection (figure 7a). For the two functionalized fields as well as for a non-functionalized reference 
field the integrated intensity is plotted normalized to the start value (figure 7b). For the measuring fields a signal 
decay is observed as is expected. The imaging detection in figure 7a reveals the inhomogeneous intensity 
behaviour across the sensor chip requiring careful consideration of these results. 
 
   
Figure 7: (a) Recorded photograph of the sensor field with the imaging read-out system at 40 minutes after injection of BSA-
biotin. The sensor field and measuring fields M1 and M2 and the reference are marked white dashed; (b) the mean value of the 
normalized intensities within the measuring and reference fields is calculated for each taken photograph and the intensity values 
are plotted against time 
3 Conclusion 
We designed and evaluated a microfluidic test chip for measuring biomarkers from whole blood. Whole blood 
filtration was performed successfully with only clear blood serum reaching the sensor cavity. Fluorescence 
measurements revealed that polymer particles with sizes larger than 3 µm remain in the filter. Imaging with our 
photonic crystal sensor yielded that even though a steady state is reached after approximately 40 seconds after an 
analyte exchange, the observed signal intensities are highly inhomogeneous. We attribute this to mechanical 
deformation of the microfluidic test chip upon fluid injection. Nevertheless, we obtained an LOD of 
7.3×10
-4
 RIU by performing refractometric measurements. Additionally, with the current sensor design the local 
binding of 500 nM BSA-biotin dissolved in phosphate buffer saline could be observed for two binding positions 
although with high signal noise. In conclusion, the approach of using a disposable microfluidic test chip and an 
imaging read-out system is promising for multiple protein detection in human blood in point-of-care 
applications. The presented results indicate how the design should be improved in the next-generation chip for 
sensitive detection. 
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